Healthcare Services Acquisition Corporation

Healthcare Services Acquisition Corporation

HCARU
Healthcare Services Acquisition CorporationUS flagNASDAQ Capital Market
10.10
USD
- -
- -
2020 Y
2021 Y
TTM
Revenue per Share
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
Dividend per Share
- -
- -
- -
Book Value per Share
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Operating Margin (%)
- -
- -
- -
Depreciation Expense
- -
- -
- -
Net Income, GAAP
- -
11
15
Effective Tax Rate (%)
- -
- -
3.03
Profit Margin (%)
- -
- -
- -
Working Capital
1
1
- -
LT Debt
- -
1
1
Total Equity
321
304
315
Return on Invested Capital (%)
- -
-1.31
-0.76
Return on Capital (%)
- -
- -
- -
Return on Common Equity (%)
- -
3.43
4.94

Capital Structure

FRC

in mil. unless spec.
Mar'22
Jun'22
Sep'22
ST Debt
- -
- -
- -
LT Borrowings
1
1
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
41
41
41
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Mar'22
Jun'22
Sep'22
Total Current Assets
1
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
1
Payables & Accruals
- -
- -
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-5.3%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
David T. Blair
Sector
Financial Services
Industry
Shell Companies
Address
7809 Woodmont Avenue Bethesda MD United States of America 20814
IPO Date
Dec 23, 2020
Business
Healthcare Services Acquisition Corporation (HCARU) operates as a blank check company, or special purpose acquisition company (SPAC), focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, primarily targeting healthcare services and related industries in the United States and Canada. The company offers no current products or services beyond its core SPAC structure, which holds investor proceeds in trust for deployment in a qualifying transaction; it does not engage in substantive operations prior to completing a business combination. Founded in 2020 and headquartered at 7809 Woodmont Avenue, Suite 200, in Bethesda, Maryland, the firm went public in December 2020 via an upsized initial public offering raising approximately $331 million, with units listed on Nasdaq under HCARU. Geographically, it concentrates on North American opportunities within healthcare services segments, including potential middle-market providers. In a major development, the company announced its liquidation and redemption of public shares in December 2022 after failing to consummate an initial business combination within the required timeframe under its charter, with shares delisted and trading suspended thereafter; no merger target was identified, and the entity remains defunct with no ongoing operations or recent strategic shifts as of 2025.

Company News

APIChat
  • Healthcare Services Acquisition Corporation Announces the Separate Trading of its Class A Common Stock and Redeemable Warrants Commencing January 5, 2021

  • Healthcare Services Acquisition Corporation closes upsized initial public offering of $331.2 million

  • Healthcare Services Acquisition Corporation Announces Pricing of Upsized $288 Million Initial Public Offering